- Home
- CBK vs FBIOP Comparison
CBK vs FBIOP Comparison
Compare CBK & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBK
- FBIOP
- Stock Information
- Founded
- CBK 1975
- FBIOP N/A
- Country
- CBK United States
- FBIOP United States
- Employees
- CBK N/A
- FBIOP 101
- Industry
- CBK Major Banks
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- CBK Finance
- FBIOP Health Care
- Exchange
- CBK Nasdaq
- FBIOP Nasdaq
- Market Cap
- CBK N/A
- FBIOP N/A
- IPO Year
- CBK 2025
- FBIOP N/A
- Fundamental
- Price
- CBK $24.45
- FBIOP $7.00
- Analyst Decision
- CBK
- FBIOP
- Analyst Count
- CBK 0
- FBIOP 0
- Target Price
- CBK N/A
- FBIOP N/A
- AVG Volume (30 Days)
- CBK 62.5K
- FBIOP N/A
- Earning Date
- CBK 10-27-2025
- FBIOP N/A
- Dividend Yield
- CBK N/A
- FBIOP N/A
- EPS Growth
- CBK N/A
- FBIOP N/A
- EPS
- CBK 2.64
- FBIOP N/A
- Revenue
- CBK $88,368,344.00
- FBIOP N/A
- Revenue This Year
- CBK N/A
- FBIOP N/A
- Revenue Next Year
- CBK N/A
- FBIOP N/A
- P/E Ratio
- CBK $9.26
- FBIOP N/A
- Revenue Growth
- CBK 10.44
- FBIOP N/A
- 52 Week Low
- CBK $23.36
- FBIOP N/A
- 52 Week High
- CBK $25.89
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- CBK N/A
- FBIOP 38.76
- Support Level
- CBK N/A
- FBIOP $6.80
- Resistance Level
- CBK N/A
- FBIOP $7.30
- Average True Range (ATR)
- CBK 0.00
- FBIOP 0.25
- MACD
- CBK 0.00
- FBIOP 0.01
- Stochastic Oscillator
- CBK 0.00
- FBIOP 43.18
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.